HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (2- benzothiazoleyl)- 4,5,6,7- tetrahydro- 2H- indazol- 3- ol

structure in first source

Also Known As:

BD750

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Benzothiazoles: 40
        2-(2-benzothiazoleyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol: 2
    - Pyrazoles: 61
      - Indazoles: 179
        2-(2-benzothiazoleyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indazoles: 179
      - 2-(2-benzothiazoleyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol: 2
    - Benzothiazoles: 40
      - 2-(2-benzothiazoleyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol: 2

Experts

1.	Leng, Xiao: 1 article (10/2017)
2.	Li, Hua: 1 article (10/2017)
3.	Li, Limei: 1 article (10/2017)
4.	Liu, Yang: 1 article (10/2017)
5.	Wang, Yantang: 1 article (10/2017)
6.	Xiong, Ying: 1 article (10/2017)
7.	Yang, Shuxia: 1 article (10/2017)
8.	Yang, Tai: 1 article (10/2017)
9.	Zhou, Yan: 1 article (10/2017)
10.	Zou, Qiang: 1 article (10/2017)

Related Diseases

1.	Autoimmune Diseases of the Nervous System 10/01/2017 - "This study aims to evaluate whether BD750 can induce tolerogenic dendritic cells (tolDC) and their function in experimental autoimmune encephalitis (EAE) in mice. " 10/01/2017 - "Tolerogenic dendritic cells induced by BD750 ameliorate proinflammatory T cell responses and experimental autoimmune encephalitis in mice."
2.	Autoimmune Diseases (Autoimmune Disease) 10/01/2017 - "BD750 and tolDC may be valuable for development of new therapies for EAE and other autoimmune diseases." 02/01/2013 - "BD750 has the potential to be used as a lead compound for the design and development of new immunosuppressants for preventing graft rejection and treating autoimmune diseases."
3.	Hypersensitivity (Allergy) 02/01/2013 - "BD750 also reduced the T cell-mediated delayed-type hypersensitivity response in mice in a dose-dependent manner. " 02/01/2013 - "The effects of BD750 were evaluated in vivo in a mouse model of delayed-type hypersensitivity. "

Related Drugs and Biologics

1.	Immunosuppressive Agents (Immunosuppressants)

Related Therapies and Procedures

1.	Therapeutics